Our Vision: Conquering Cancer Together

  Our Vision: Conquering Cancer Together

Nebraska’s Key Role in the Detection, Treatment, and Support of Hereditary Cancer Families: A Journey from Past to Present and Beyond.

  • Wednesday, March 13, 2024
  • 12:00 PM - 1:00 PM
  • Zoom webinar - link included with registration



 Vision: Conquer Cancer Together

Mission: Connecting people and resources to strengthen cancer prevention, detection and quality of life in Nebraska.

Nebraska's Key Role in the Detection, Treatment , and Support of Hereditary  Cancer Families: A Journey From Past to Present and Beyond

Wednesday, March 13, 2024

12p-1p CST

About the Webinar: 

This talk will provide an overview of hereditary cancers–i.e., cancers that run in families due to inherited genetic risk factors. It will particularly highlight the contributions of Dr. Henry Lynch, a former Creighton University clinician-researcher for whom Lynch Syndrome was named. 

Learning Objectives: 

1) Describe the contributions of Dr. Henry Lynch's research to the modern identification and treatment of hereditary cancer families.

2) Examine how our knowledge and utilization of hereditary cancer genetics have evolved over the past 50 years.

3) Discuss where gaps remain in the genetic architecture of hereditary cancer risk.

About the Speaker

Holly Feser Stessman, PhD, is currently an Assistant Professor of Pharmacology & Neuroscience within the Creighton University Medical School. Her research interests revolve around the role that genetic variation plays in complex disease diagnoses and treatments. She received her PhD in 2013 from the University of Minnesota–Twin Cities where her work focused around molecular mechanism of chemoresistance in cancer treatment. She continued with this human genetics research focus, working as a Postdoctoral Fellow from 2013-2016 at the University of Washington in the Genome Sciences department. In addition to her interests in autism genetics, Dr. Stessman also manages the Lynch Memorial Biorepository at Creighton. Established by Dr. Henry Lynch, Dr. Stessman has worked to maintain the integrity and utility of this extensive hereditary cancer family collection. In addition, she continues to work with this collection to identify known risk factors in at-risk families and to discovery novel hereditary cancer genetic risk variants.


Continuing Education

1.0 Continuing Education Contact Hours awarded by Iowa Western Community College, Iowa Board of Nursing Provider #6

NC2 webinars are included as a member benefit. Non-members will be charged $25/webinar OR can join as a member for $25/year to access all webinars.

Information for webinar will be included with your confirmation email and calendar invite.

In order to help us better track webinar attendance, you will also need to enter your name and email via Zoom.


Nebraska Cancer Coalition © 2024  •  5100 N 27th Street, Suite A2, Lincoln, NE 68521 •  NC2 is a 501(c)3 non-profit organization

Powered by Wild Apricot Membership Software